Cargando…
A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
Lassa virus (LASV) poses a significant public health problem within the regions of Lassa fever endemicity in Western Africa. LASV infects several hundred thousand individuals yearly, and a considerable number of Lassa fever cases are associated with high morbidity and lethality. No approved LASV vac...
Autores principales: | Cai, Yingyun, Iwasaki, Masaharu, Motooka, Daisuke, Liu, David X., Yu, Shuiqing, Cooper, Kurt, Hart, Randy, Adams, Ricky, Burdette, Tracey, Postnikova, Elena N., Kurtz, Jonathan, St. Claire, Marisa, Ye, Chengjin, Kuhn, Jens H., Martínez-Sobrido, Luis, de la Torre, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157513/ https://www.ncbi.nlm.nih.gov/pubmed/32209677 http://dx.doi.org/10.1128/mBio.00186-20 |
Ejemplares similares
-
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
por: Cai, Yingyun, et al.
Publicado: (2020) -
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
por: Caì, Yíngyún, et al.
Publicado: (2018) -
Genome rearrangements with indels in intergenes restrict the scenario space
por: Bulteau, Laurent, et al.
Publicado: (2016) -
Approximation algorithm for rearrangement distances considering repeated genes and intergenic regions
por: Siqueira, Gabriel, et al.
Publicado: (2021) -
Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)